Jessika Carr

Kennedy Lewis Launches Partnership with iCapital to Bring Differentiated Private Credit Strategy to Advisors and their Clients

Retrieved on: 
Wednesday, December 13, 2023
Investment, Partnership, Creativity, Environment, Jessika Carr, Bank, Financial services

NEW YORK, Dec. 13, 2023 /PRNewswire/ -- Kennedy Lewis Investment Management LLC ("Kennedy Lewis"), a leading alternative credit manager, announced that it has launched a partnership with iCapital, the global fintech platform driving access to alternative investments for the wealth management industry, which will initially focus on Kennedy Lewis' core lending strategy.

Key Points: 
  • As a result, Kennedy Lewis' core lending strategy is intended to provide portfolio diversification benefits when compared to other direct lending strategies.
  • Kennedy Lewis has approximately $14 billion under management and has been investing in the non-sponsor backed private credit space since its founding in 2017.
  • "Advisors are extremely interested in offering their clients institutional-quality private credit strategies, and we are excited to add Kennedy Lewis to our platform," said Lawrence Calcano, Chairman and CEO of iCapital.
  • "Kennedy Lewis' deep expertise within credit provides advisors and their clients with access to differentiated investment opportunities."

Curonix Celebrates 1st Anniversary

Retrieved on: 
Wednesday, November 1, 2023
SCS, Education, Jessika Carr, PNS, Freedom, Physician, American Medical Association, AMA, Society, HF, Safety, Patient, Nursing, Pharmaceutical industry

POMPANO BEACH, Fla., Nov. 01, 2023 (GLOBE NEWSWIRE) -- Today, Curonix LLC, a leading peripheral nerve stimulation company celebrated its first anniversary.

Key Points: 
  • POMPANO BEACH, Fla., Nov. 01, 2023 (GLOBE NEWSWIRE) -- Today, Curonix LLC, a leading peripheral nerve stimulation company celebrated its first anniversary.
  • In November 2022, Curonix completed the purchase of substantially all assets, excluding liabilities, of Stimwave Technologies.
  • “Curonix is a new company that was formed to deliver much-needed non-opioid chronic pain relief with our innovative HF-EMC technology platform.
  • “We are excited to support Curonix as it serves patients and physicians,” said David Kho, Curonix Chairman of the Board, and Managing Director at Kennedy Lewis.